In the same model, when treated with cyclophosphamide-loaded PD-1 presenting platelets, Tregs (FoxP3+) decreased at the tumor site and tumor infiltrating CD8+ T cells significantly increased. The gene discussed is CD8A; the disease is neoplasm.